drugset
drugset / Trial / NCT00721188

Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients

NCT00721188 ↗

Phase 2 Completed 11 enrolled American Regent, Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The primary objective of this study is to assess the pharmacokinetics of Venofer (Iron Sucrose Injection) in NDD-CKD pediatric patients.

Timeline

Start
2006-01
Primary completion
2008-07
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron sucrose Unknown 7 mg/kg Intravenous

Indications

anemia